Penumbra (PEN) Asset Writedowns and Impairment (2014 - 2026)
Penumbra (PEN) posted quarterly Asset Writedowns and Impairment of $852000.0 for Q2 2026, down 47.86% quarter-over-quarter from $1.6 million in Q1 2026.
Penumbra (PEN) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Asset Writedowns and Impairment for 13 consecutive years, with $852000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to $852000.0; the TTM figure through Jun 2026 stood at $4.1 million (up 63.1% YoY), while the FY2025 annual figure was $5.8 million, down 92.46% from the prior year.
- Asset Writedowns and Impairment slipped to $852000.0 in Q2 2026 per PEN's latest filing, from $1.6 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $76.9 million in Q2 2024 and bottomed at $358000.0 in Q1 2024.
- Historically, Asset Writedowns and Impairment has averaged $7.4 million across 5 years, with a median of $994500.0 in 2022.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment slumped 64.52% — and 2025, when it jumped 594.13%.
- Penumbra's Asset Writedowns and Impairment stood at $1.4 million in 2022, then sank by 31.85% to $950000.0 in 2023, then surged by 7994.74% to $76.9 million in 2024, then plunged by 97.96% to $1.6 million in 2025, then tumbled by 45.63% to $852000.0 in 2026.
- Business Quant data shows PEN's Asset Writedowns and Impairment at $852000.0 in Q2 2026, $1.6 million in Q1 2026, and $1.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Penumbra | 12.78 Bn | 12.13 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 852,000.00 |
| Jun 30, 2026 | 852,000.00 |
| Mar 31, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | -4.23 Mn |
| Dec 31, 2025 | -4.23 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Jun 30, 2024 | 76.90 Mn |
| Jun 30, 2024 | 76.90 Mn |
| Mar 31, 2024 | 358,000.00 |
| Mar 31, 2024 | 358,000.00 |
| Dec 31, 2023 | -5.25 Mn |
| Dec 31, 2023 | -5.25 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 478,000.00 |
| Sep 30, 2022 | 478,000.00 |